# Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization

Study · id `cardio:ct-nct05624190` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05624190](<https://clinicaltrials.gov/study/NCT05624190>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05624190

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 256 participants.

## Technical summary

Registry record NCT05624190. Randomized; single masking; primary purpose treatment. Start 2023-02-16 (actual); primary completion 2024-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 256 participants (planned count; ClinicalTrials.gov record NCT05624190, source copy `cardio:ctgov-nct05624190-2024-03-19`, retrieved 2026-11-18)
- Started: 2023-02-16 (actual) (ClinicalTrials.gov record NCT05624190, source copy `cardio:ctgov-nct05624190-2024-03-19`, retrieved 2026-11-18)
- Primary completion: 2024-07 (anticipated) (ClinicalTrials.gov record NCT05624190, source copy `cardio:ctgov-nct05624190-2024-03-19`, retrieved 2026-11-18)
- Completion: 2024-07 (anticipated) (ClinicalTrials.gov record NCT05624190, source copy `cardio:ctgov-nct05624190-2024-03-19`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT05624190, source copy `cardio:ctgov-nct05624190-2024-03-19`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05624190-2024-03-19`, retrieved 2026-11-18)

## The registry's words

- Brief title: Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization
- Acronym: ANGEL-TNK
- Condition: Ischemic Stroke, Acute
- Intervention (Drug): Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA)
- Intervention (Other): Best Medical Management
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy: The ANGEL-TNK Randomized Clinical Trial (`cardio:pubmed-40616323`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2b5b75339334c21ae21cdebebb8c6fc6ea4cb187f5db7945464fce93b9f82731
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
